Skip to content
lifestyle.thriveinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Latigo Biotherapeutics, Inc
Latigo Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
November 5, 2026
Latigo Biotherapeutics Announces CEO Transition to Support the Company’s Next Phase of Growth
November 5, 2026
Latigo Biotherapeutics to Participate in Upcoming Investor Conferences in November
November 3, 2026
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
September 3, 2026
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
August 6, 2026